OC10.05: *Increased nuchal translucency in congenital heart defects: associations with mortality
نویسندگان
چکیده
The objective was to investigate if increased NT associated with mortality in children CHD. In a nationwide cohort using population-based registries, 5,633 liveborn Denmark pre or postnatal diagnosis of CHD from 2008-2018 (0.7%) were identified. Children lack data on first trimester screening, chromosomal abnormalities no match between registries excluded. Increased defined as > 3.5 mm 1.5 Multiples Median (MoM). Proportions compared chi-squared test significance level 0.05. Of 4,469 eventually included the cohort, 754 (17%) had complex and 3,715 (83%) simple these, 239 (5.3%) an >1.5 MoM, 57 (1.3%) >3.5 mm. Mortality higher MoM than <1.5 (3.3% vs. 1.5%, p = 0.03). for when (2.3% vs 0.6%, 0.01). Amongst undergoing surgery significantly found group (8.6% 2.5%, 0.04). Complex more frequent (27% 16%, < 0.01), but not (6.1% 5.8%, 0.93) there difference (4.3% 7.5%, 0.44). Due limited numbers association could be assessed. Confounding birth variables: gestational age, birthweight, small preterm birth, pre-eclampsia, placental weight, maternal smoking, BMI, beta-HcG, PAPP-A equally distributed MoM. born CHD, mortality. primarily evident infants possibly independent predictor
منابع مشابه
Why increased nuchal translucency is associated with congenital heart disease: a systematic review on genetic mechanisms.
This overview provides insight into the underlying genetic mechanism of the high incidence of cardiac defects in fetuses with increased nuchal translucency (NT). Nuchal edema, the morphological equivalent of increased NT, is likely to result from abnormal lymphatic development and is strongly related to cardiac defects. The underlying genetic pathways are, however, unknown. This study aims to p...
متن کاملThe Role of Nuchal Translucency in the Screening of Congenital Heart Defects
Three thousand six hundred and sixty four gestations were analyzed, of which twenty newborn infants had some congenital heart defect up to the first month of life (prevalence of 0.55%). The median NT in fetuses with CHD was 1.70 mm, and 1.60 mm in fetuses without CHD. However no statistically significant difference was observed between the two medians (Mann-Whitney test, p > 0.05). The NT sensi...
متن کاملThe role of nuchal translucency in the screening for congenital heart defects.
OBJECTIVE Assess the accuracy of the nuchal translucency (NT) measurement between 11 and 13 weeks and 6 days of gestation as a sonographic marker to screen for congenital heart defects (CHD). METHODS This is a multi-center retrospective study in which singleton gestations of euploid fetuses were analyzed. NT measurement was performed in the first trimester examination when the fetal crown-rum...
متن کاملOutcome of pregnancies with increased nuchal translucency
Methods A total of 1490 pregnant women were assessed for first trimester ultrasonography. They had routinely measured crown-rump length (CRL) and nuchal translucency (NT) for screening for Down syndrome between 11 and 14 weeks of gestation. Cases with a NT≥3 mm were counselled further regarding the risk of chromosomal abnormality and prenatal diagnosis by fetal karyotyping. A complete follow-up...
متن کامل[Increased nuchal translucency with normal karyotype].
Nuchal translucency (NT) measurement in first trimester screening between 11 and 14 weeks' gestation has now been clearly identified as a marker for aneuploidies and in particular for trisomy 21. Even in the absence of aneuploidy increased fetal nuchal translucency has been shown to be a marker for fetal heart malformations and numerous other fetal defects and genetic syndromes when the measure...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Ultrasound in Obstetrics & Gynecology
سال: 2021
ISSN: ['1469-0705', '0960-7692']
DOI: https://doi.org/10.1002/uog.23851